OARSI recommendations for the management of hip and knee OA
18. Treatment with glucosamine and/or chondroitin
sulphate may provide symptomatic benefit in
patients with knee OA. If no response is apparent
within 6 months treatment should be discontinued.
SOR: 63% (95% CI 44e82)
|